These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 24362794)
1. Txr1: an important factor in oxaliplatin resistance in gastric cancer. Bi J; Bai Z; Ma X; Song J; Guo Y; Zhao J; Yi X; Han S; Zhang Z Med Oncol; 2014 Feb; 31(2):807. PubMed ID: 24362794 [TBL] [Abstract][Full Text] [Related]
2. Taxol-Resistant Gene 1 (Txr1) Mediates Oxaliplatin Resistance by Inducing Autophagy in Human Nasopharyngeal Carcinoma Cells. Chi HM; Du JD; Cheng J; Mao HD Med Sci Monit; 2019 Jan; 25():475-483. PubMed ID: 30650069 [TBL] [Abstract][Full Text] [Related]
3. Tumoral expression of TXR1 and TSP1 predicts overall survival of patients with lung adenocarcinoma treated with first-line docetaxel-gemcitabine regimen. Papadaki C; Mavroudis D; Trypaki M; Koutsopoulos A; Stathopoulos E; Hatzidaki D; Tsakalaki E; Georgoulias V; Souglakos J Clin Cancer Res; 2009 Jun; 15(11):3827-33. PubMed ID: 19435835 [TBL] [Abstract][Full Text] [Related]
4. Effects of taxol resistance gene 1 expression on the chemosensitivity of SGC-7901 cells to oxaliplatin. Liu L; Bai Z; Ma X; Wang T; Yang Y; Zhang Z Exp Ther Med; 2016 Mar; 11(3):846-852. PubMed ID: 26998002 [TBL] [Abstract][Full Text] [Related]
5. Nuclear PRMT1 expression is associated with poor prognosis and chemosensitivity in gastric cancer patients. Altan B; Yokobori T; Ide M; Mochiki E; Toyomasu Y; Kogure N; Kimura A; Hara K; Bai T; Bao P; Suzuki M; Ogata K; Asao T; Nishiyama M; Oyama T; Kuwano H Gastric Cancer; 2016 Jul; 19(3):789-97. PubMed ID: 26472729 [TBL] [Abstract][Full Text] [Related]
6. TXR1 and TSP1 expression varies by the molecular subtypes of breast cancer patients who received previous docetaxel-based first-line chemotherapy. Zhang H; Qu X; Ma X; Wang T; Yang Y; Ge Z; Zhang Z; Bai Z; Gao Y; Yuan Z; Wang Z Exp Biol Med (Maywood); 2016 Nov; 241(17):1919-1923. PubMed ID: 27407097 [TBL] [Abstract][Full Text] [Related]
7. Correlation of BRCA1, TXR1 and TSP1 mRNA expression with treatment outcome to docetaxel-based first-line chemotherapy in patients with advanced/metastatic non-small-cell lung cancer. Papadaki C; Tsaroucha E; Kaklamanis L; Lagoudaki E; Trypaki M; Tryfonidis K; Mavroudis D; Stathopoulos E; Georgoulias V; Souglakos J Br J Cancer; 2011 Jan; 104(2):316-23. PubMed ID: 21157449 [TBL] [Abstract][Full Text] [Related]
8. The relationships between the chemosensitivity of human gastric cancer to paclitaxel and the expressions of class III β-tubulin, MAPT, and survivin. He W; Zhang D; Jiang J; Liu P; Wu C Med Oncol; 2014 May; 31(5):950. PubMed ID: 24722794 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of BMI-1 correlates with drug resistance in B-cell lymphoma cells through the stabilization of survivin expression. Bhattacharyya J; Mihara K; Ohtsubo M; Yasunaga S; Takei Y; Yanagihara K; Sakai A; Hoshi M; Takihara Y; Kimura A Cancer Sci; 2012 Jan; 103(1):34-41. PubMed ID: 21999765 [TBL] [Abstract][Full Text] [Related]
10. Up-regulation of survivin by AKT and hypoxia-inducible factor 1α contributes to cisplatin resistance in gastric cancer. Sun XP; Dong X; Lin L; Jiang X; Wei Z; Zhai B; Sun B; Zhang Q; Wang X; Jiang H; Krissansen GW; Qiao H; Sun X FEBS J; 2014 Jan; 281(1):115-28. PubMed ID: 24165223 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of forkhead box M1 transcription factor (FOXM1) is a potential prognostic marker and enhances chemoresistance for docetaxel in gastric cancer. Okada K; Fujiwara Y; Takahashi T; Nakamura Y; Takiguchi S; Nakajima K; Miyata H; Yamasaki M; Kurokawa Y; Mori M; Doki Y Ann Surg Oncol; 2013 Mar; 20(3):1035-43. PubMed ID: 23054116 [TBL] [Abstract][Full Text] [Related]
12. Anti-tumor effects of CIK combined with oxaliplatin in human oxaliplatin-resistant gastric cancer cells in vivo and in vitro. Zhao Q; Zhang H; Li Y; Liu J; Hu X; Fan L J Exp Clin Cancer Res; 2010 Aug; 29(1):118. PubMed ID: 20799994 [TBL] [Abstract][Full Text] [Related]
13. Establishment of oxaliplatin-resistant gastric cancer organoids: importance of myoferlin in the acquisition of oxaliplatin resistance. Harada K; Sakamoto N; Ukai S; Yamamoto Y; Pham QT; Taniyama D; Honma R; Maruyama R; Takashima T; Ota H; Takemoto Y; Tanabe K; Ohdan H; Yasui W Gastric Cancer; 2021 Nov; 24(6):1264-1277. PubMed ID: 34272617 [TBL] [Abstract][Full Text] [Related]
14. Effect of tissue factor on invasion inhibition and apoptosis inducing effect of oxaliplatin in human gastric cancer cell. Yu YJ; Li YM; Hou XD; Guo C; Cao N; Jiao ZY Asian Pac J Cancer Prev; 2012; 13(5):1845-9. PubMed ID: 22901134 [TBL] [Abstract][Full Text] [Related]
15. Lysyl oxidase-like 4 (LOXL4) promotes proliferation and metastasis of gastric cancer via FAK/Src pathway. Li RK; Zhao WY; Fang F; Zhuang C; Zhang XX; Yang XM; Jiang SH; Kong FZ; Tu L; Zhang WM; Yang SL; Cao H; Zhang ZG J Cancer Res Clin Oncol; 2015 Feb; 141(2):269-81. PubMed ID: 25216702 [TBL] [Abstract][Full Text] [Related]
16. Expression of taxol resistance gene 1 correlates with gastric cancer patient clinical outcome and induces taxol resistance. Bai ZG; Qu X; Han W; Ma XM; Zhao XM; Zhang ZT Mol Med Rep; 2010; 3(6):1071-8. PubMed ID: 21472357 [TBL] [Abstract][Full Text] [Related]
17. Expression and clinical significance of long non-coding RNA HNF1A-AS1 in human gastric cancer. Dang Y; Lan F; Ouyang X; Wang K; Lin Y; Yu Y; Wang L; Wang Y; Huang Q World J Surg Oncol; 2015 Oct; 13():302. PubMed ID: 26472090 [TBL] [Abstract][Full Text] [Related]
18. Oxaliplatin in treatment of the cisplatin-resistant MKN45 cell line of gastric cancer. Tozawa K; Oshima T; Kobayashi T; Yamamoto N; Hayashi C; Matsumoto T; Miwa H Anticancer Res; 2008; 28(4B):2087-92. PubMed ID: 18751380 [TBL] [Abstract][Full Text] [Related]
19. Role of integrin-linked kinase in multi-drug resistance of human gastric carcinoma SGC7901/DDP cells. Song W; Jiang R; Zhao CM Asian Pac J Cancer Prev; 2012; 13(11):5619-25. PubMed ID: 23317227 [TBL] [Abstract][Full Text] [Related]
20. Oxaliplatin activates P53/miR-34a/survivin axis in inhibiting the progression of gastric cancer cells. Guo Q; Wang XY; Zhai YC; Dong YW; He QS Immun Inflamm Dis; 2024 Sep; 12(9):e70004. PubMed ID: 39254476 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]